LNTH Stock Analysis: Buy, Sell, or Hold?
LNTH - Lantheus Holdings, Inc
$106.34
0.70 (0.66%)
▲
5d:
+3.42%
30d:
+6.09%
90d:
+31.95%
BUY
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 05, 2026
22d
Get Alerted When LNTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LNTH shows positive signals but monitor for confirmation. Market pricing in 7.5% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: LNTH shows positive signals but monitor for confirmation. Market pricing in 7.5% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$144.10
Based on 11.2% avg growth
INTRINSIC VALUE TODAY
$89.48
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LNTH is currently trading at $106.34, which is considered fair relative to its 30-day fair value range of $100.64 to $108.19. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.6) compared to its historical average (13.4). At these levels, the market is pricing in 7.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LNTH is in a strong uptrend. Immediate support is located at $99.63, while resistance sits at $111.86.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LNTH is in a strong uptrend. Immediate support is located at $99.63, while resistance sits at $111.86.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$100.64 -
$108.19
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($110.33)
- NEUTRAL: Trading at premium valuation - market expects 7.5% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$100.64 -
$108.19
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$99.63
Resistance Level
$111.86
Current Trend
Strong Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.58
Wall Street Target
$110.33
(+4.4%)
Revenue Growth (YoY)
1.2%
Earnings Growth (YoY)
76.5%
Profit Margin
18.1%
Valuation Premium vs History
+7.5% premium
PE vs Historical
16.6 vs 13.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.5%
(market-implied from PE analysis)
1-Year Target
$113.56
(+8%)
2-Year Target
$122.08
(+16%)
3-Year Target
$131.24
(+24%)
3-Yr Target (if PE normalizes)
(PE: 17→13)
PE COMPRESSION
$106.07
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 18.3%)
$230.02
(+118%)
Base:
(SPY PE: 16.6, Growth: 18.3%)
$175.09
(+66%)
Bear:
(PE: 13.4, Growth: 18.3%)
$141.52
(+34%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 25.42 | Current EPS (TTM): $4.17
Bull Case
$178.15
(+69%)
Analyst growth 52.8%, PE expands to 28.0
Base Case
$161.96
(+53%)
Market implied 52.8%, PE stable at 25.4
Bear Case
$72.07
(-32%)
Severe decline -20.0%, PE contracts to 21.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 10:16 AM ET
Data refreshes hourly during market hours. Next update: 11:16 AM
Data refreshes hourly during market hours. Next update: 11:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 66 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$116 | 64 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 57 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
Advanced LNTH Option Strategies
Professional options setups generated by AI based on today's LNTH price and gamma walls.
